Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons

Background. Antiretroviral preexposure prophylaxis (PrEP), using daily oral combination tenofovir disoproxil fumarate plus emtricitabine, is an effective human immunodeficiency virus (HIV) prevention strategy for populations at high risk of HIV acquisition. Although the primary mode of action for th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Infect Dis
Main Authors: Pattacini, Laura, Murnane, Pamela M., Baeten, Jared M., Fluharty, Tayler R., Thomas, Katherine K., Bukusi, Elizabeth, Katabira, Elly, Mugo, Nelly, Donnell, Deborah, Lingappa, Jairam R., Celum, Connie, Marzinke, Mark, McElrath, M. Juliana, Lund, Jennifer M.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2015
Teme:
Major Articles and Brief Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4836720/
https://ncbi.nlm.nih.gov/pubmed/25520426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu815
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki